Interpreting missense variants: comparing computational methods in human disease genesCDKN2A,MLH1,MSH2,MECP2, and tyrosinase (TYR)-Reference-Cited by-同舟云学术

Interpreting missense variants: comparing computational methods in human disease genesCDKN2A,MLH1,MSH2,MECP2, and tyrosinase (TYR)

Published:2007-07 Issue:7 Volume:28 Page:683-693
ISSN:1059-7794
Container-title:Human Mutation
language:en
Short-container-title:Hum. Mutat.

Author:

Chan Philip A.,Duraisamy Sekhar,Miller Peter J.,Newell Joan A.,McBride Carole,Bond Jeffrey P.,Raevaara Tiina,Ollila Saara,Nyström Minna,Grimm Andrew J.,Christodoulou John,Oetting William S.,Greenblatt Marc S.

Publisher

Wiley

Subject

Genetics(clinical),Genetics

Reference49 articles.

1. Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation;Abkevich;J Med Genet,2004

2. Point mutations can inactivate in vitro and in vivo activities of p16(INK4a)/CDKN2A in human glioma;Arap;Oncogene,1997

3. Sequence variation in G-protein-coupled receptors: analysis of single nucleotide polymorphisms;Balasubramanian;Nucleic Acids Res,2005

4. Prediction of the phenotypic effects of non-synonymous single nucleotide polymorphisms using structural and evolutionary information;Bao;Bioinformatics,2005

5. Functional impairment of melanoma-associated p16(INK4a) mutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding;Becker;Clin Cancer Res,2001

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biallelic TYR and TKFC variants in Egyptian patients with OCA1 and new expanded TKFC features;BMC Genomics;2024-09-09

2. Inter-BRCT linker is probably the most intolerant region of the BRCA1 BRCT domain;Journal of Biomolecular Structure and Dynamics;2023-11-10

3. Interpreting protein variant effects with computational predictors and deep mutational scanning;Disease Models & Mechanisms;2022-06-01

4. Genome interpretation using in silico predictors of variant impact;Human Genetics;2022-04-30

5. Splice-disrupt genomic variants in prostate cancer;Molecular Biology Reports;2022-03-14